Suppr超能文献

重症监护病房患者血浆中洋地黄样免疫反应性物质:与器官功能障碍的关系

Digoxin-like immunoreactive substances in the plasma of intensive care unit patients: relationship to organ dysfunction.

作者信息

Howarth D M, Sampson D C, Hawker F H, Young A

机构信息

Royal Prince Alfred Hospital, Sydney, N.S.W.

出版信息

Anaesth Intensive Care. 1990 Feb;18(1):45-52. doi: 10.1177/0310057X9001800108.

Abstract

Digoxin-like immunoreactive substances are an endogenous group of compounds that cross-react in conventional immunoassays for digoxin. Plasma digoxin-like immunoreactive substance concentrations were estimated using the Abbott TDxll fluorescence polarisation immunoassay kit for digoxin. Digoxin-like immunoreactive substances were measured in one hundred consecutive Intensive Care Unit (ICU) patients who were not treated with digoxin. One hundred healthy blood donors were used as controls. Thirty of the ICU patients had plasma digoxin-like immunoreactive substance concentrations greater than or equal to the greatest value found in the control group (0.22 nmol/l). In the ICU group the median value was 0.17 nmol/l and the range zero to 1.69 nmol/l. In the control group the median was less than the limit of detection of the assay, and the range zero to 0.22 nmol/l. Sixteen ICU patients had coexisting renal and hepatic dysfunction and this group had a median digoxin-like immunoreactive substance concentration of 0.21 nmol/l (range zero to 1.69 nmol/l), while 38 patients with hepatic dysfunction and normal renal function had a median concentration of 0.17 nmol/l (range zero to 0.77 nmol/l). In contrast four patients with renal dysfunction only had a median concentration of 0.05 nmol/l (range zero to 0.34 nmol/l). The remaining forty-two patients had neither hepatic nor renal dysfunction and this group had a median concentration of 0.15 nmol/l (range zero to 0.36 nmol/l). This study has identified the critically ill as a group of patients who exhibit measurable plasma digoxin-like immunoreactive substances using the most commonly used kit for analysis of digoxin.

摘要

地高辛样免疫反应性物质是一类内源性化合物,它们在传统的地高辛免疫测定中会发生交叉反应。使用雅培TDxll地高辛荧光偏振免疫测定试剂盒估算血浆地高辛样免疫反应性物质的浓度。对100例未接受地高辛治疗的重症监护病房(ICU)连续患者测量了地高辛样免疫反应性物质。100名健康献血者作为对照。30例ICU患者的血浆地高辛样免疫反应性物质浓度大于或等于对照组中发现的最大值(0.22 nmol/l)。ICU组的中位数为0.17 nmol/l,范围为0至1.69 nmol/l。对照组的中位数低于该测定的检测限,范围为0至0.22 nmol/l。16例ICU患者同时存在肝肾功能不全,该组地高辛样免疫反应性物质浓度中位数为0.21 nmol/l(范围为0至1.69 nmol/l),而38例肝功能不全但肾功能正常的患者浓度中位数为0.17 nmol/l(范围为0至0.77 nmol/l)。相比之下,仅4例肾功能不全患者的浓度中位数为0.05 nmol/l(范围为0至0.34 nmol/l)。其余42例患者既无肝功能不全也无肾功能不全,该组浓度中位数为0.15 nmol/l(范围为0至0.36 nmol/l)。本研究已确定危重症患者是使用最常用的地高辛分析试剂盒可检测出血浆地高辛样免疫反应性物质的一组患者。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验